Minority patients underrepresented in Covid-19 trials despite greater willingness to participate, report finds

Minority patients underrepresented in Covid-19 trials despite greater willingness to participate, report finds

Source: 
Endpoints
snippet: 

Black participants made up only 9.7% and 9.8% of Moderna and Pfizer/BioNTech’s Phase III vaccine trials, respectively — despite representing just over 13% of the US population. Hispanic or Latinx volunteers made up 20% and 26.2%, which is actually over census levels. But American Indian and Alaska Native volunteers? Just 0.8% and 0.6% of the trials, respectively.